β-Adrenergic Receptor-Mediated Cardiac Contractility is Inhibited via Vasopressin Type 1A-Receptor-Dependent Signaling

BACKGROUND: Enhanced arginine vasopressin (AVP) levels are associated with increased mortality during end-stage human heart failure (HF), and cardiac AVP type 1A receptor (V1AR) expression becomes increased. Additionally, mice with cardiac-restricted V1AR overexpression develop cardiomyopathy and de...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Circulation
Glavni autori: Tilley, Douglas G., Zhu, Weizhong, Myers, Valerie D., Barr, Larry A., Gao, Erhe, Li, Xue, Song, Jianliang, Carter, Rhonda L., Makarewich, Catherine A., Yu, Daohai, Troupes, Constantine D., Grisanti, Laurel A., Coleman, Ryan C., Koch, Walter J., Houser, Steven R., Cheung, Joseph Y., Feldman, Arthur M.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229385/
https://ncbi.nlm.nih.gov/pubmed/25205804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.010434
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items